Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Raskas Daniel | SVP - Corporate Development | Nov 26 '24 | Option Exercise | 58.59 | 26,318 | 1,541,972 | 41,543 | Nov 27 05:01 PM | Raskas Daniel | SVP - Corporate Development | Nov 26 '24 | Sale | 236.59 | 26,318 | 6,226,497 | 15,225 | Nov 27 05:01 PM | Raskas Daniel | SVP - Corporate Development | Nov 25 '24 | Sale | 238.00 | 8,370 | 1,992,060 | 15,225 | Nov 27 05:01 PM | Raskas Daniel | Officer | Nov 26 '24 | Proposed Sale | 236.59 | 26,318 | 6,226,496 | | Nov 26 04:40 PM | Raskas Daniel | Officer | Nov 25 '24 | Proposed Sale | 238.00 | 8,370 | 1,992,060 | | Nov 25 12:04 PM | Glenstone Foundation | See Remarks | Nov 05 '24 | Proposed Sale | 247.76 | 100,000 | 24,776,000 | | Nov 05 04:01 PM | Weidemanis Joakim | Former Director | Oct 23 '24 | Proposed Sale | 254.95 | 17,659 | 4,502,216 | | Oct 23 01:10 PM | Couchara Georgeann | SVP, Human Resources | Aug 26 '24 | Sale | 268.37 | 952 | 255,483 | 4,212 | Aug 27 05:04 PM | Couchara Georgeann | Officer | Aug 26 '24 | Proposed Sale | 268.37 | 952 | 255,483 | | Aug 26 04:40 PM | Glenstone Foundation | See Remarks | Aug 13 '24 | Proposed Sale | 267.20 | 47,937 | 12,808,766 | | Aug 13 04:05 PM | Blair Rainer | President & CEO | Jul 31 '24 | Sale | 280.00 | 9,007 | 2,521,960 | 97,983 | Aug 02 05:00 PM | FILLER LINDA | Director | Aug 01 '24 | Option Exercise | 59.34 | 3,928 | 233,088 | 45,077 | Aug 02 05:00 PM | FILLER LINDA | Director | Aug 01 '24 | Sale | 279.50 | 3,928 | 1,097,876 | 41,149 | Aug 02 05:00 PM | McGrew Matthew | EVP & Chief Financial Officer | Aug 01 '24 | Option Exercise | 62.85 | 16,172 | 1,016,410 | 45,579 | Aug 02 05:00 PM | McGrew Matthew | EVP & Chief Financial Officer | Aug 01 '24 | Sale | 279.84 | 16,172 | 4,525,555 | 29,407 | Aug 02 05:00 PM | McGrew Matthew | Officer | Aug 01 '24 | Proposed Sale | 279.84 | 16,172 | 4,525,555 | | Aug 01 04:28 PM | FILLER LINDA | Director | Aug 01 '24 | Proposed Sale | 279.50 | 3,928 | 1,097,876 | | Aug 01 12:27 PM | Blair Rainer | Officer | Jul 31 '24 | Proposed Sale | 280.00 | 9,007 | 2,521,960 | | Jul 31 04:26 PM | Ellis Brian W | Senior Vice President - GC | Jul 25 '24 | Sale | 275.16 | 9,600 | 2,641,536 | 20,230 | Jul 26 05:03 PM | Raskas Daniel | SVP - Corporate Development | Jul 25 '24 | Sale | 270.51 | 14,507 | 3,924,352 | 23,595 | Jul 26 05:03 PM | Zerhouni Elias A. | Director | Jul 15 '24 | Option Exercise | 52.56 | 3,289 | 172,870 | 37,483 | Jul 16 05:01 PM | SCHWIETERS JOHN T | Director | Jul 15 '24 | Option Exercise | 52.56 | 3,289 | 172,870 | 19,808 | Jul 16 05:00 PM | King William | SVP, Strategic Development | May 15 '24 | Option Exercise | 50.37 | 12,623 | 635,821 | 55,208 | May 17 05:10 PM | Blair Rainer | President & CEO | May 16 '24 | Sale | 265.00 | 9,005 | 2,386,325 | 106,990 | May 17 05:08 PM | Blair Rainer | President & CEO | May 14 '24 | Option Exercise | 59.91 | 19,085 | 1,143,435 | 135,080 | May 15 05:00 PM | Blair Rainer | President & CEO | May 14 '24 | Sale | 255.00 | 19,085 | 4,866,675 | 115,995 | May 15 05:00 PM | McGrew Matthew | EVP & Chief Financial Officer | May 10 '24 | Option Exercise | 61.25 | 25,174 | 1,541,794 | 45,338 | May 13 05:01 PM | McGrew Matthew | EVP & Chief Financial Officer | May 10 '24 | Sale | 253.05 | 46,377 | 11,735,856 | 29,407 | May 13 05:01 PM | SPOON ALAN G | Director | May 02 '24 | Option Exercise | 52.56 | 3,289 | 172,870 | 116,910 | May 03 05:03 PM | SPOON ALAN G | Director | May 02 '24 | Sale | 243.58 | 708 | 172,455 | 116,202 | May 03 05:03 PM | Weidemanis Joakim | Executive Vice President | Apr 25 '24 | Option Exercise | 58.48 | 22,433 | 1,311,882 | 112,845 | Apr 26 05:00 PM | Weidemanis Joakim | Executive Vice President | Apr 25 '24 | Sale | 250.46 | 22,433 | 5,618,569 | 90,412 | Apr 26 05:00 PM | Ellis Brian W | Senior Vice President - GC | Apr 24 '24 | Sale | 250.01 | 4,000 | 1,000,040 | 29,830 | Apr 25 05:00 PM | Blair Rainer | President & CEO | Apr 24 '24 | Option Exercise | 59.91 | 38,170 | 2,286,870 | 154,165 | Apr 25 05:00 PM | Blair Rainer | President & CEO | Apr 24 '24 | Sale | 249.22 | 47,175 | 11,756,725 | 115,995 | Apr 25 05:00 PM | Raskas Daniel | SVP - Corporate Development | Feb 26 '24 | Option Exercise | 58.48 | 23,757 | 1,389,309 | 61,859 | Feb 27 05:01 PM | Raskas Daniel | SVP - Corporate Development | Feb 26 '24 | Sale | 252.00 | 23,757 | 5,986,764 | 38,102 | Feb 27 05:01 PM | LOHR WALTER G | Director | Feb 15 '24 | Option Exercise | 52.56 | 3,289 | 172,870 | 17,418 | Feb 16 05:01 PM | LOHR WALTER G | Director | Feb 15 '24 | Sale | 251.15 | 3,289 | 826,032 | 14,129 | Feb 16 05:01 PM | Couchara Georgeann | SVP, Human Resources | Feb 13 '24 | Option Exercise | 70.71 | 2,622 | 185,414 | 6,022 | Feb 14 05:00 PM | Couchara Georgeann | SVP, Human Resources | Feb 13 '24 | Sale | 242.67 | 2,622 | 636,290 | 4,244 | Feb 14 05:00 PM | List Teri | Director | Feb 06 '24 | Option Exercise | 52.56 | 3,289 | 172,870 | 23,015 | Feb 08 05:00 PM | List Teri | Director | Feb 06 '24 | Sale | 248.32 | 3,289 | 816,724 | 19,726 | Feb 08 05:00 PM |
|